Skip to main content

Peer Review reports

From: The impact of ABCB1 and CES1 polymorphisms on the safety of dabigatran in patients with non-valvular atrial fibrillation

Original Submission
11 Apr 2022 Submitted Original manuscript
26 Jul 2022 Reviewed Reviewer Report
19 Sep 2022 Reviewed Reviewer Report
27 Sep 2022 Author responded Author comments - Jie Pan
Resubmission - Version 2
27 Sep 2022 Submitted Manuscript version 2
13 Oct 2022 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
21 Oct 2022 Editorially accepted
11 Nov 2022 Article published 10.1186/s12872-022-02910-4

You can find further information about peer review here.

Back to article page